MYX logo

Mayne Pharma Group Limited Stock Price

ASX:MYX Community·AU$394.0m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 7 Fair Values set on narratives written by author

MYX Share Price Performance

AU$4.85
-0.03 (-0.61%)
AU$4.85
-0.03 (-0.61%)
Price AU$4.85

MYX Community Narratives

There are no narratives available yet.

Snowflake Analysis

Excellent balance sheet and slightly overvalued.

1 Risk
1 Reward

Mayne Pharma Group Limited Key Details

AU$408.1m

Revenue

AU$160.8m

Cost of Revenue

AU$247.3m

Gross Profit

AU$337.3m

Other Expenses

-AU$90.1m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-1.11
60.59%
-22.07%
9.5%
View Full Analysis

About MYX

Founded
2005
Employees
491
CEO
Shawn O’Brien
WebsiteView website
www.maynepharma.com

Mayne Pharma Group Limited, a specialty pharmaceutical company, focuses on the commercialization of women’s health and dermatology pharmaceuticals in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. It operates through three segments: Women’s Health, Dermatology, and International. The company provides oral drug delivery systems, as well as contract development and manufacturing services to third-party customers. It also distributes specialty pharmaceutical products in the dermatology, women’s health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.

Recent MYX News & Updates

Recent updates

No updates